New Tool Helps Identify Lung Cancer Patients Who Will Respond to Immune Therapies
Wednesday, February 4, 2015 - 17:30
in Health & Medicine
A Yale-led team of researchers has developed a new assay, or investigative tool, to measure the anti-tumor immune activity in non-small cell lung cancer tumors that could lead to a more accurate determination of which patients will respond to immune therapy drugs. Findings from the study were published in the Journal of the National Cancer Institute.